News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
85,784 Results
Type
Article (4767)
Company Profile (28)
Press Release (80987)
Multimedia
Podcasts (1)
Webinars (2)
Section
Business (29175)
Career Advice (72)
Deals (4605)
Drug Delivery (11)
Drug Development (6896)
Employer Resources (7)
FDA (1156)
Job Trends (1876)
News (37830)
Policy (2840)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (511)
Accelerated approval (7)
ADA (2)
Allergies (5)
Alliances (8218)
ALS (30)
Alzheimer's disease (202)
Antibody-drug conjugate (ADC) (45)
Approvals (1225)
Artificial intelligence (212)
ASCO (55)
Autoimmune disease (31)
Automation (17)
Bankruptcy (34)
Belgium (11)
Best Places to Work (1468)
BIO (11)
Biologics (4)
BIOSECURE Act (12)
Biosimilars (7)
BioSpace Insights (11)
Biotechnology (34)
Bispecific (2)
Bladder cancer (31)
Brain cancer (15)
Breast cancer (223)
Cancer (1179)
Cardiovascular disease (28)
Career advice (74)
Career pathing (2)
CAR-T (39)
CDC (2)
CDMO (16)
Celiac Disease (1)
Cell therapy (151)
Cervical cancer (3)
Clinical research (5615)
Collaboration (487)
Commercialization (1)
Compensation (48)
Complete response letters (2)
COVID-19 (432)
CRISPR (62)
C-suite (197)
Cystic fibrosis (13)
Data (1080)
Denatured (1)
Depression (12)
Dermatology (5)
Diabetes (33)
Diagnostics (1977)
Digital health (8)
Diversity, equity & inclusion (4)
Drug discovery (88)
Drug pricing (2)
Drug shortages (1)
Duchenne muscular dystrophy (24)
Earnings (8207)
Editorial (1)
Employer branding (1)
Employer resources (7)
ESMO (56)
Events (12039)
Executive appointments (184)
FDA (1507)
Fragile X (3)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (256)
Gene editing (140)
Generative AI (11)
Gene therapy (128)
GLP-1 (65)
Government (420)
Guidances (36)
Healthcare (2271)
Hematology (22)
HIV (6)
Huntington's disease (16)
IgA nephropathy (7)
Immunology and inflammation (10)
Immuno-oncology (18)
Indications (22)
Infectious disease (472)
Inflammatory bowel disease (17)
Influenza (11)
Intellectual property (31)
Interviews (8)
IPO (1901)
Job creations (445)
Job search strategy (67)
JPM (2)
Kidney disease (12)
Labor market (4)
Layoffs (29)
Legal (813)
Licensing (3)
Liver cancer (11)
Longevity (11)
Lung cancer (171)
Lymphoma (44)
Machine learning (15)
Management (2)
Manufacturing (127)
MASH (6)
Medical device (1119)
Medtech (1136)
Mergers & acquisitions (2902)
Metabolic disorders (62)
mRNA (41)
Multiple sclerosis (10)
NASH (1)
Netherlands (2)
Neurodegenerative disease (55)
Neuropsychiatric disorders (3)
Neuroscience (362)
NextGen: Class of 2026 (658)
Non-profit (410)
Now hiring (5)
Obesity (18)
Opinion (34)
Ovarian cancer (16)
Pain (30)
Pancreatic cancer (70)
Parkinson's disease (36)
Partnered (16)
Patents (74)
Patient recruitment (59)
Patient selection (5)
Peanut (1)
People (8859)
Peptides (1)
Pharmaceutical (6)
Phase 1 (2102)
Phase 2 (2769)
Phase 3 (1674)
Pipeline (1157)
Policy (19)
Postmarket research (103)
Preclinical (1082)
Press Release (24)
Prostate cancer (57)
Psychedelics (3)
Radioligand (1)
Radiopharmaceuticals (35)
Rare diseases (188)
Real estate (638)
Recruiting (1)
Regenerative medicine (2)
Regulatory (2117)
Reports (29)
Research institute (608)
Resumes & cover letters (2)
Rett syndrome (14)
RNA editing (5)
RSV (3)
Schizophrenia (12)
Series A (37)
Series B (19)
Service/supplier (2)
Sickle cell disease (32)
Spinal muscular atrophy (4)
Sponsored (7)
Startups (555)
State (1)
Stem cells (2)
Supply chain (12)
Tariffs (1)
Vaccines (82)
Venture capital (8)
Weight loss (7)
Women's health (6)
Date
Today (19)
Last 7 days (117)
Last 30 days (352)
Last 365 days (3398)
2026 (2954)
2025 (3559)
2024 (4628)
2023 (5364)
2022 (7203)
2021 (8152)
2020 (6631)
2019 (4895)
2018 (3732)
2017 (3911)
2016 (3792)
2015 (4215)
2014 (3041)
2013 (2565)
2012 (2738)
2011 (2757)
2010 (2719)
Location
Africa (102)
Alabama (12)
Alaska (1)
Arizona (40)
Arkansas (1)
Asia (3922)
Australia (519)
California (1862)
Canada (1426)
China (117)
Colorado (64)
Connecticut (139)
Delaware (27)
Europe (9022)
Florida (245)
Georgia (17)
Hawaii (2)
Idaho (5)
Illinois (109)
India (13)
Indiana (78)
Iowa (13)
Japan (90)
Kansas (10)
Kentucky (7)
Louisiana (6)
Maine (6)
Maryland (208)
Massachusetts (1154)
Michigan (73)
Minnesota (108)
Mississippi (1)
Missouri (16)
Montana (12)
Nebraska (8)
Nevada (20)
New Hampshire (13)
New Jersey (463)
New Mexico (14)
New York (449)
North Carolina (303)
North Dakota (11)
Northern California (942)
Ohio (51)
Oklahoma (4)
Oregon (3)
Pennsylvania (325)
Puerto Rico (1)
Rhode Island (12)
South America (110)
South Carolina (5)
Southern California (705)
Tennessee (20)
Texas (455)
United States (6345)
Utah (70)
Virginia (25)
Washington D.C. (5)
Washington State (84)
Wisconsin (56)
Wyoming (3)
85,784 Results for "quantum genomics corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lumen is Redefining Networking for the AI and Quantum Eras
October 29, 2026
·
6 min read
Press Releases
Trenchant Technologies Capital Corp. Completes Unwinding of Previous Limitless Quantum Acquisition and Corporate Updates
April 22, 2026
·
5 min read
Press Releases
Quantum-Si Reports Third Quarter 2026 Financial Results and Provides Business Update
November 6, 2026
·
19 min read
Press Releases
INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro ™
October 14, 2026
·
1 min read
Press Releases
TELO Genomics Expands Multi-Center Clinical Studies to Advance Comparative Validation of TELO-MRD Against Next-Generation Sequencing
In matched multi-center cohorts, Telo Genomics is expanding comparative evaluation of blood-based TELO-MRD against Adaptive Biotechnologies’ clonoSEQ next-generation sequencing MRD testing.
October 29, 2026
·
6 min read
Press Releases
FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health
November 2, 2026
·
10 min read
Press Releases
HEALTH CANADA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-release Injectable Suspension) from Merck Animal Health
November 2, 2026
·
4 min read
Press Releases
Quantum-Si Demonstrates Detection of 19 Amino Acids in Proteus™ Development Program
October 8, 2026
·
6 min read
Press Releases
Allosteric Bioscience, Inc. Targets Optimizing Aging and Longevity: Quantum Computing, Advanced AI, Genomics
March 5, 2026
·
1 min read
Press Releases
SciSparc: Subsidiary NeuroThera Labs’ Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics
July 31, 2026
·
4 min read
1 of 8,579
Next
